Scientific roundtable discussion

PPAR Presentations

PPAR 2004

Genentech, South San Francisco, CA

Meeting Overview

The 2004 PPAR materials reflect a formative period of PAT definition, regulatory development, and organizational benchmarking. Discussion areas included FDA PAT Guidance, international regulatory perspectives, benchmarking of PAT/PAC organizations, biotech manufacturing technologies, student training, and vendor audit practices.

Discussion Focus

  • FDA PAT Guidance
  • International regulatory perspectives
  • PAT/PAC organization benchmarking
  • Biotech manufacturing technologies
  • Student training
  • Vendor audit practices

Available Materials

Benchmarking


Regulatory / FDA


Biotech / Process Monitoring


Workforce / Training


Vendor / Standards

Key Topics

  • FDA PAT Guidance
  • Benchmarking
  • Biotech manufacturing
  • Regulatory strategy
  • Vendor audits
  • Student training
  • PAT organization